The Role of Epigenetics in the Induction of Fetal Hemoglobin: A Combination Therapy Approach

Autor: Ahmadvand, M., Noruzinia, M., Dehghani Fard, A., Mostafa Montazer zohour, Amin Tabatabaiefar, M., Soleimani, M., Kaviani, S., Abroun, S., Beiranvand, S., Saki, N.

Publikováno v: International Journal of Hematology-Oncology and Stem Cell Research, Vol 8, Iss 1 (2014)
Scopus-Elsevier
International Journal of Hematology-Oncology and Stem Cell Research

Background: β-thalassemia considers worldwide public health disorders. Novel fetal hemoglobin inducer agents such as thalidomide and sodium butyrate have been attended for ameliorating clinical complications of such disorders. Material and Methods:

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9ee4b0a1a099a9425b88409af5761eae
https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/433

A novel METTL5 variant disrupting a donor splice site leads to primary microcephaly-related intellectual disability in an Iranian family: clinical features and literature review.

Autor: Shakarami F; Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran.tabatabaiefar@med.mui.ac.ir., Nouri Z, Khanahmad H, Ghazavi M, Amin Tabatabaiefar M

Publikováno v: Journal of genetics [J Genet] 2023; Vol. 102.